CVRx, Inc. (CVRX) Insider Trading

Last 12 months

Insiders bought $377k and sold $130k on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market

+$247k

3 buys · 6 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

2 / 6

executives and directors

Last open-market buy

Aug 2026

Aug 13, 2026

Get an email when CVRX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 13	Brent Binkowski CHIEF OPERATING OFFICER	Bought	26,223	$2.91	$76k	87%	Form 4
Aug 12	Brent Binkowski CHIEF OPERATING OFFICER	Sold10b5-1 plan	1,309	$2.55	$3k	4.1%	Form 4
Mar 2	Philip B. Adamson Chief Medical Officer	Sold10b5-1 plan	1,262	$7.90	$10k	2.0%	Form 4
Mar 2	Robert Allen John Chief Revenue Officer	Sold10b5-1 plan	3,964	$7.90	$31k	4.4%	Form 4
Mar 2	Paul Verrastro CHIEF MKTG & STRAT OFFICER	Sold10b5-1 plan	1,284	$7.90	$10k	2.1%	Form 4
Mar 2	Jared Oasheim CHIEF FINANCIAL OFFICER	Sold10b5-1 plan	1,744	$7.90	$14k	1.8%	Form 4
Mar 2	Kevin Hykes PRES & CEO	Sold10b5-1 plan	7,763	$7.90	$61k	2.7%	Form 4
Feb 20	Mudit K. Jain Director	Bought	46,800	$6.36	$298k	5.0%	Form 4
Feb 18	Mudit K. Jain Director	Bought	600	$4.64	$3k	<0.1%	Form 4
Nov 25, 2025 – Nov 26, 2025	Johnson & Johnson Innovation - Jjdc, Inc. Large holder	SoldNo plan 2 parts	22,337	$10.03 average	$224k	0.6%	Form 4
Nov 26, 2025	& Johnson Johnson Large holder	SoldNo plan	6,337	$10.03	$64k	0.2%	Form 4
Nov 21, 2025 – Nov 24, 2025	& Johnson Johnson Large holder	SoldNo plan 2 parts	2,700	$10.05 average	$27k	<0.1%	Form 4
Nov 12, 2025	& Johnson Johnson Large holder	SoldNo plan	1,000	$10.00	$10k	<0.1%	Form 4
Nov 6, 2025 – Nov 7, 2025	Johnson & Johnson Innovation - Jjdc, Inc. Large holder	SoldNo plan 2 parts	52,532	$10.21 average	$536k	1.3%	Form 4
May 15, 2025	Kirk G. Nielsen Director	Bought	10,966	$5.45	$60k	0.6%	Form 4
May 12, 2025 – May 14, 2025	Kirk G. Nielsen Director	Bought 3 parts	187,813	$5.20 average	$977k	11%	Form 4
May 12, 2025 – May 13, 2025	Mudit K. Jain Director	Bought 2 parts	1,650	$4.71 average	$8k	0.2%	Form 4
May 12, 2025	Kevin Hykes PRES & CEO	Bought	5,000	$4.84	$24k	3.9%	Form 4
Nov 19, 2024	Paul Verrastro CHIEF MKTG & STRAT OFFICER	SoldNo plan	1,430	$13.58	$19k	63%	Form 4

Aug 13
Brent Binkowski
CHIEF OPERATING OFFICER · bought 26,223 at $2.91
$76k
87% of stake
Aug 1210b5-1 plan
Brent Binkowski
CHIEF OPERATING OFFICER · sold 1,309 at $2.55
$3k
4.1% of stake
Mar 210b5-1 plan
Philip B. Adamson
Chief Medical Officer · sold 1,262 at $7.90
$10k
2.0% of stake
Mar 210b5-1 plan
Robert Allen John
Chief Revenue Officer · sold 3,964 at $7.90
$31k
4.4% of stake
Mar 210b5-1 plan
Paul Verrastro
CHIEF MKTG & STRAT OFFICER · sold 1,284 at $7.90
$10k
2.1% of stake
Mar 210b5-1 plan
Jared Oasheim
CHIEF FINANCIAL OFFICER · sold 1,744 at $7.90
$14k
1.8% of stake
Mar 210b5-1 plan
Kevin Hykes
PRES & CEO · sold 7,763 at $7.90
$61k
2.7% of stake
Feb 20
Mudit K. Jain
Director · bought 46,800 at $6.36
$298k
5.0% of stake
Feb 18
Mudit K. Jain
Director · bought 600 at $4.64
$3k
<0.1% of stake
Nov 25, 2025 – Nov 26, 2025No plan
Johnson & Johnson Innovation - Jjdc, Inc.
Large holder · sold 22,337 at avg $10.03
$224k
0.6% of stake
Nov 26, 2025No plan
& Johnson Johnson
Large holder · sold 6,337 at $10.03
$64k
0.2% of stake
Nov 21, 2025 – Nov 24, 2025No plan
& Johnson Johnson
Large holder · sold 2,700 at avg $10.05
$27k
<0.1% of stake
Nov 12, 2025No plan
& Johnson Johnson
Large holder · sold 1,000 at $10.00
$10k
<0.1% of stake
Nov 6, 2025 – Nov 7, 2025No plan
Johnson & Johnson Innovation - Jjdc, Inc.
Large holder · sold 52,532 at avg $10.21
$536k
1.3% of stake
May 15, 2025
Kirk G. Nielsen
Director · bought 10,966 at $5.45
$60k
0.6% of stake
May 12, 2025 – May 14, 2025
Kirk G. Nielsen
Director · bought 187,813 at avg $5.20
$977k
11% of stake
May 12, 2025 – May 13, 2025
Mudit K. Jain
Director · bought 1,650 at avg $4.71
$8k
0.2% of stake
May 12, 2025
Kevin Hykes
PRES & CEO · bought 5,000 at $4.84
$24k
3.9% of stake
Nov 19, 2024No plan
Paul Verrastro
CHIEF MKTG & STRAT OFFICER · sold 1,430 at $13.58
$19k
63% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CVRX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

LNSRLensar Inc.

SIShoulder Innovations, Inc.

CARLCarlsmed, Inc.

VEROVenus Concept Inc.

APYXApyx Medical Corporation

SSIISS Innovations International, Inc.

RCELAvita Medical Inc.

KRMDKoru Medical Systems Inc.

Spot a number that looks wrong? Check it in CVRX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CVRX

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.